Ultragenyx Pharmaceutical Operating Expenses 2012-2024 | RARE
Ultragenyx Pharmaceutical operating expenses for the twelve months ending June 30, 2024 were $1.030B, a 4.23% decline year-over-year.
- Ultragenyx Pharmaceutical annual operating expenses for 2023 were $1.003B, a 0.87% decline from 2022.
- Ultragenyx Pharmaceutical annual operating expenses for 2022 were $1.012B, a 38.07% increase from 2021.
- Ultragenyx Pharmaceutical annual operating expenses for 2021 were $0.733B, a 21.96% increase from 2020.